HCW Biologics Inc.
HCWB· Nasdaq
HCWBHCW Biologics Inc.
Filed Aug 12, 2022 · 10-Q · 43 days after period end · 0000950170-22-017015
| Metric | Q2 2022 | Q2 2021 | Q2 2020 |
|---|---|---|---|
| Revenue | $454.00K | $0.00 | $0.00 |
| Net Income | -$3.51M | -$2.75M | -$2.78M |
| EPS Diluted | -$0.10 | -$0.66 | -$0.65 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
HCW Biologics Inc. · CIK 1828673 · Engraved from SEC EDGAR
ended Jun 30, 2022 · filed Aug 12, 2022 · 43 d after period end
